TY - JOUR
T1 - The effect of depressive symptoms on disability-free survival in healthy older adults
T2 - A prospective cohort study
AU - Roebuck, Greg
AU - Lotfaliany, Mojtaba
AU - Agustini, Bruno
AU - Forbes, Malcolm
AU - Mohebbi, Mohammadreza
AU - McNeil, John
AU - Woods, Robyn L.
AU - Reid, Christopher M.
AU - Nelson, Mark R.
AU - Shah, Raj C.
AU - Ryan, Joanne
AU - Newman, Anne B.
AU - Owen, Alice
AU - Freak-Poli, Rosanne
AU - Stocks, Nigel
AU - Berk, Michael
AU - the ASPREE Investigator Group
N1 - Funding Information:
U.S. National Institutes of Health, Grant/Award Numbers: U19AG062682, U01AG029824; National Health and Medical Research Council of Australia, Grant/Award Numbers: 1127060, 1081901, 334047; Monash University; Victorian Cancer Agency; NHMRC Investigator Grant, Grant/Award Number: 1173690; NHMRC Principal Research Fellowship, Grant/Award Number: 1136372; NHMRC Boosting Dementia Research Leader Fellowship, Grant/Award Number: 1135727; National Heart Foundation of Australia Post‐Doctoral Fellowship, Grant/Award Number: 101927; NHMRC Senior Principal Research Fellowship, Grant/Award Number: 1156072 Funding information
Funding Information:
ASPREE was supported by grants from the National Institute on Ageing and the National Cancer Institute at the U.S. National Institutes of Health (U01AG029824 and U19AG062682); the National Health and Medical Research Council of Australia (NHMRC) (334047, 1081901 and 1127060); Monash University (Australia) and the Victorian Cancer Agency (Australia). JM is supported by a NHMRC Investigator Grant (1173690), CMR by a NHMRC Principal Research Fellowship (1136372), JR by a NHMRC Boosting Dementia Research Leader Fellowship (1135727), RFP by a National Heart Foundation of Australia Post‐Doctoral Fellowship (101927) and MB by a NHMRC Senior Principal Research Fellowship (1156072). We would like to thank the ASPREE participants who volunteered for this study, the general practitioners and staff of the medical clinics who support the study participants and the trial staff and management team of the ASPREE study in Australia and the United States ( www.aspree.org ).
Publisher Copyright:
© 2022 The Authors. Acta Psychiatrica Scandinavica published by John Wiley & Sons Ltd.
PY - 2023/1
Y1 - 2023/1
N2 - Background: Gerontology and ageing research are increasingly focussing on healthy life span (healthspan), the period of life lived free of serious disease and disability. Late-life depression (LLD) is believed to impact adversely on physical health. However, no studies have examined its effect on healthspan. This study investigated the effect of LLD and subthreshold depression on disability-free survival, a widely accepted measure of healthspan. Methods: This prospective cohort study used data from the ASPirin in Reducing Events in the Elderly study. Participants were aged ≥70 years (or ≥65 years for African-American and Hispanic participants) and free of dementia, physical disability and cardiovascular disease. Depressive symptoms were measured using the 10-item Centre for Epidemiological Studies Depression Scale (CES-D-10). LLD and subthreshold depression were defined as CES-D-10 scores ≥8 and 3–7, respectively. Disability-free survival was defined as survival free of dementia and persistent physical disability. Results: A total of 19,110 participants were followed up for a maximum of 7.3 years. In female participants, LLD was associated with lower disability-free survival adjusting for sociodemographic and lifestyle factors, medical comorbidities, polypharmacy, physical function and antidepressant use (HR, 1.50; 95% CI, 1.23–1.82). In male participants, LLD was associated with lower disability-free survival adjusting for sociodemographic and lifestyle factors (HR, 1.30; 95% CI, 1.03–1.64). Subthreshold depression was also associated with lower disability-free survival in both sexes. Conclusions: LLD may be a common and important risk factor for shortened healthspan.
AB - Background: Gerontology and ageing research are increasingly focussing on healthy life span (healthspan), the period of life lived free of serious disease and disability. Late-life depression (LLD) is believed to impact adversely on physical health. However, no studies have examined its effect on healthspan. This study investigated the effect of LLD and subthreshold depression on disability-free survival, a widely accepted measure of healthspan. Methods: This prospective cohort study used data from the ASPirin in Reducing Events in the Elderly study. Participants were aged ≥70 years (or ≥65 years for African-American and Hispanic participants) and free of dementia, physical disability and cardiovascular disease. Depressive symptoms were measured using the 10-item Centre for Epidemiological Studies Depression Scale (CES-D-10). LLD and subthreshold depression were defined as CES-D-10 scores ≥8 and 3–7, respectively. Disability-free survival was defined as survival free of dementia and persistent physical disability. Results: A total of 19,110 participants were followed up for a maximum of 7.3 years. In female participants, LLD was associated with lower disability-free survival adjusting for sociodemographic and lifestyle factors, medical comorbidities, polypharmacy, physical function and antidepressant use (HR, 1.50; 95% CI, 1.23–1.82). In male participants, LLD was associated with lower disability-free survival adjusting for sociodemographic and lifestyle factors (HR, 1.30; 95% CI, 1.03–1.64). Subthreshold depression was also associated with lower disability-free survival in both sexes. Conclusions: LLD may be a common and important risk factor for shortened healthspan.
KW - ageing
KW - disability-free survival
KW - healthspan
KW - late-life depression
KW - psychiatry
UR - https://www.scopus.com/pages/publications/85142032817
U2 - 10.1111/acps.13513
DO - 10.1111/acps.13513
M3 - Article
C2 - 36281968
AN - SCOPUS:85142032817
SN - 0001-690X
VL - 147
SP - 92
EP - 104
JO - Acta Psychiatrica Scandinavica
JF - Acta Psychiatrica Scandinavica
IS - 1
ER -